Cite
MLA Citation
A Astarita et al.. “Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events.” European heart journal, vol. 22, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100121927082.0x000019